In ₹ Crore except Per Share Latest Annual	SUNPHARMA FY26	CIPLA FY26	DRREDDY FY26	LUPIN FY26	Peer Average
Valuation — at last close
P/E	36.84×	28.27×	26.68×	◆ 17.04×	24.00× +54%
P/B	5.06×	3.19×	◆ 2.96×	4.05×	3.40× +49%
EV/EBITDA	22.24×	17.18×	17.32×	◆ 9.95×	14.82× +50%
Market Cap	₹4.23L Cr	₹1.10L Cr	₹1.12L Cr	₹90,978 Cr	₹1.04L Cr +305%
Growth
Revenue CAGR 3Y	10.03%	7.37%	10.96%	◆ 18.88%	12.40% -19%
Revenue CAGR 5Y	11.78%	8.01%	12.09%	◆ 13.02%	11.04% +7%
Net Income CAGR 3Y	10.57%	10.88%	-2.66%	◆ 128.70%	45.64% -77%
Revenue YoY (latest Q)	10.46%	-2.44%	-1.48%	◆ 32.04%	9.37% +12%
Net Income YoY (latest Q)	◆ 26.53%	-37.08%	-31.69%	16.01%	-17.59% +251%
Profitability
EBITDA Margin	30.33%	20.89%	19.15%	◆ 31.53%	23.86% +27%
Net Income Margin	◆ 19.69%	13.71%	12.34%	19.16%	15.07% +31%
Return on Common Equity	14.74%	11.82%	11.75%	◆ 26.90%	16.82% -12%
Return on Capital Employed	18.48%	13.87%	11.30%	◆ 32.38%	19.18% -4%
Return on Assets	11.46%	9.67%	7.73%	◆ 15.85%	11.08% +3%
Credit & Quality
Total Debt/Equity	0.05×	◆ 0.01×	0.16×	0.26×	0.14× -65%
Interest Coverage	43.65×	◆ 85.90×	11.76×	17.12×	38.26× +14%
Scale — latest FY
Revenue / Total Income	₹58,462 Cr	₹28,163 Cr	₹33,700 Cr	₹27,958 Cr	₹29,940 Cr +95%
Net Income	₹11,509 Cr	₹3,862 Cr	₹4,158 Cr	₹5,355 Cr	₹4,458 Cr +158%
Total Assets	₹1.09L Cr	₹42,496 Cr	₹58,123 Cr	₹38,365 Cr	₹46,328 Cr +135%
EPS	₹47.8	₹48.03	₹50.41	₹116.75	₹71.73 -33%
Book Value per Share	₹348.31	₹426.24	₹453.79	₹490.99	₹457.01 -24%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 199%.